NEW YORK (GenomeWeb News) – At a public meeting held by the US Food and Drug Administration in Washington, DC, today focused on ways to create more transparency in agency affairs, the advocacy group Genetic Alliance advised the FDA to host a registry for genetic tests and lab tests, and that it share all of its warning letters with the public.

FDA held the meeting to listen to recommendations from the public about how to make information about its activities more useful, understandable, and accessible.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.